The timing of onset of hypophysitis is earliest with combination therapy with median 1–3 months, followed with anti-CTLA-4 monotherapy (median 9–11 weeks), and usually later with anti-PD-1/PD-L1 monotherapy with median 4–7 months. The gene discussed is CTLA4; the disease is hypophysitis.